• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?

作者信息

Lemoli Roberto M, D'Addio Alessandra

机构信息

Department of Hematology and Oncological Sciences "L. &  A. Seràgnoli", Institute of Hematology, University of Bologna.

出版信息

Rev Bras Hematol Hemoter. 2011;33(3):172-3. doi: 10.5581/1516-8484.20110044.

DOI:10.5581/1516-8484.20110044
PMID:23049286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3415742/
Abstract
摘要

相似文献

1
Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?在造血干细胞移植中使用白消安加美法仑的预处理方案：该预处理方案能否用于急性白血病的自体或异基因移植？
Rev Bras Hematol Hemoter. 2011;33(3):172-3. doi: 10.5581/1516-8484.20110044.
2
Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in Japan.比较儿童急性髓细胞白血病自体干细胞移植的预处理方案：日本全国性回顾性研究。
Pediatr Blood Cancer. 2019 Jan;66(1):e27459. doi: 10.1002/pbc.27459. Epub 2018 Sep 30.
3
[Hematopoietic stem cell transplantation with conditioning regimens containing melphalan in pediatric patients with acute lymphoblastic leukemia].
Rinsho Ketsueki. 2002 Jul;43(7):527-37.
4
Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older.50 岁及以上异基因移植受者中氟达拉滨/白消安与氟达拉滨/马法兰预处理方案的比较。
Biol Blood Marrow Transplant. 2017 Dec;23(12):2079-2087. doi: 10.1016/j.bbmt.2017.09.003. Epub 2017 Sep 7.
5
Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.氟达拉滨与白消安的减低剂量预处理方案对比氟达拉滨与美法仑用于急性髓细胞白血病患者：欧洲血液与骨髓移植组急性白血病工作组的报告
Cancer. 2015 Apr 1;121(7):1048-55. doi: 10.1002/cncr.29163. Epub 2014 Nov 25.
6
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.在接受异基因造血干细胞移植的首次完全缓解的急性髓系白血病患者中，与白消安加环磷酰胺相比，白消安加氟达拉滨作为清髓性预处理方案：一项前瞻性多中心研究。
J Hematol Oncol. 2013 Feb 8;6:15. doi: 10.1186/1756-8722-6-15.
7
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.静脉注射白消安和马法兰作为新诊断多发性骨髓瘤患者自体干细胞移植的预处理方案：与仅用马法兰方案的匹配比较。
Biol Blood Marrow Transplant. 2013 Jan;19(1):69-74. doi: 10.1016/j.bbmt.2012.08.009. Epub 2012 Aug 13.
8
[High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma].在多发性骨髓瘤自体干细胞移植中，高剂量美法仑（HDM）作为预处理方案优于环磷酰胺加依托泊苷及白消安（CVB）。
Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):732-737. doi: 10.3760/cma.j.issn.0253-2727.2019.09.004.
9
Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission.在首次完全缓解的伴有不良预后细胞遗传学的急性髓系白血病患者中进行异基因造血细胞移植的预处理强度。
Biol Blood Marrow Transplant. 2020 Mar;26(3):463-471. doi: 10.1016/j.bbmt.2019.09.025. Epub 2019 Sep 25.
10
[Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].[采用FLAG序贯白消安/环磷酰胺预处理方案进行异基因造血干细胞移植治疗难治/复发急性髓系白血病的临床结局]
Zhonghua Nei Ke Za Zhi. 2018 Aug 1;57(8):576-581. doi: 10.3760/cma.j.issn.0578-1426.2018.08.008.

引用本文的文献

1
[Control study of melphalan instead of cyclophosphamide as a myeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation for treatment of myeloid malignancies].[美法仑替代环磷酰胺作为异基因造血干细胞移植治疗髓系恶性肿瘤清髓预处理方案的对照研究]
Zhonghua Xue Ye Xue Za Zhi. 2015 Oct;36(10):835-9. doi: 10.3760/cma.j.issn.0253-2727.2015.10.006.

本文引用的文献

1
BU/melphalan and auto-SCT in AML patients in first CR: a 'Gruppo Italiano Trapianto di Midollo Osseo (GITMO)' retrospective study.BU/melphalan 和自体造血干细胞移植在首次完全缓解的 AML 患者中的应用：一项来自意大利骨髓移植组（Gruppo Italiano Trapianto di Midollo Osseo，GITMO）的回顾性研究。
Bone Marrow Transplant. 2010 Apr;45(4):640-6. doi: 10.1038/bmt.2009.235. Epub 2009 Oct 5.
2
High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation.大剂量美法仑是治疗难治性复发及自体干细胞移植后复发的急性髓系白血病患者的一种有效挽救疗法。
Ann Hematol. 2005 Oct;84(11):748-54. doi: 10.1007/s00277-005-1075-8. Epub 2005 Jul 7.
3
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma.美法仑与美法仑加白消安用于低危多发性骨髓瘤自体干细胞移植预处理的比较
Hematol J. 2004;5(2):118-22. doi: 10.1038/sj.thj.6200369.
4
High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.大剂量美法仑联合自体造血干细胞移植治疗急性髓系白血病：意大利儿科骨髓移植小组的回顾性分析结果
Bone Marrow Transplant. 2001 Jul;28(2):131-6. doi: 10.1038/sj.bmt.1703122.
5
Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.儿童急性髓系白血病强化治疗的结果，包括在首次完全缓解时采用大剂量美法仑和自体骨髓移植。
Blood. 1993 Dec 15;82(12):3730-8.